AAAAAA
Results:
1-8
|
Results: 8
Authors:
Eichner, JE
Christiansen, VJ
Moore, WE
Dunn, ST
Schechter, E
Citation: Je. Eichner et al., Angiotensin-converting enzyme gene polymorphism in a cohort of coronary angiography patients, ATHEROSCLER, 154(3), 2001, pp. 673-679
Authors:
Schechter, E
Citation: E. Schechter, Constructivism is difficult, AM MATH MO, 108(1), 2001, pp. 50-54
Authors:
Rashdan, I
Schechter, E
Citation: I. Rashdan et E. Schechter, Safety and efficacy of abciximab use in conjunction with intracoronary urokinase in patients requiring angioplasty, CATHET C IN, 49(1), 2000, pp. 113-116
Authors:
Mobley, BA
Schechter, E
Moore, WE
McKee, PA
Eichner, JE
Citation: Ba. Mobley et al., Predictions of coronary artery stenosis by artificial neural network, ARTIF INT M, 18(3), 2000, pp. 187-203
Authors:
Biles, DC
Schechter, E
Citation: Dc. Biles et E. Schechter, Solvability of a finite or infinite system of discontinuous quasimonotone differential equations, P AM MATH S, 128(11), 2000, pp. 3349-3360
Authors:
Barsness, GW
Buller, C
Ohman, M
Schechter, E
Pucillo, A
Taylor, MA
Miller, MJ
Reiner, JS
Churchill, D
Chandler, AB
Gonzalez, M
Smith, J
Tommaso, C
Berdan, LG
Wildermann, NM
Hasdai, D
Holmes, DR
Citation: Gw. Barsness et al., Reduced thrombus burden with abciximab delivered locally before percutaneous intervention saphenous vein grafts, AM HEART J, 139(5), 2000, pp. 824-829
Authors:
Abramov, Y
Naparstek, Y
Elchalal, U
Lewin, A
Schechter, E
Schenker, JG
Citation: Y. Abramov et al., Plasma immunoglobulins in patients with severe ovarian hyperstimulation syndrome, FERT STERIL, 71(1), 1999, pp. 102-105
Authors:
Teirstein, PS
Mann, JT
Cundey, PE
Schechter, E
Jacobs, WC
Grines, CL
Stagaman, DJ
Kansky, AJ
Hultquist, MA
Kusnick, BA
Heuser, RR
Kleinert, HD
Popma, J
Citation: Ps. Teirstein et al., Low- versus high-dose recombinant urokinase for the treatment of chronic saphenous vein graft occlusion, AM J CARD, 83(12), 1999, pp. 1623-1628
Risultati:
1-8
|